BRISTOL MYERS SQUIBB CO
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
BMY | US
Overview
Corporate Details
- ISIN(s):
- US1101222073 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- ROUTE 206 AND PROVINCE LINE ROAD, 8543 PRINCETON
- Website:
- https://www.bms.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. The company's primary focus is on therapeutic areas with significant unmet medical needs, including oncology, hematology, immunology, and cardiovascular disease. Its operations encompass the full lifecycle of drug development, from scientific research and clinical trials to manufacturing, marketing, and distribution of its products worldwide. The company is committed to transforming patients' lives through scientific innovation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-10 17:06 |
Regulatory News Service
FORM 8-K
|
English | 1.6 MB | ||
| 2025-11-07 17:11 |
Prospectus
424B5
|
English | 673.2 KB | ||
| 2025-11-05 22:50 |
Regulatory News Service
FWP
|
English | 17.4 KB | ||
| 2025-11-04 23:19 |
Director's Dealing
FORM 4
|
English | 7.4 KB | ||
| 2025-11-04 23:18 |
Director's Dealing
FORM 4
|
English | 8.2 KB | ||
| 2025-11-04 23:15 |
Director's Dealing
FORM 4
|
English | 7.5 KB | ||
| 2025-11-04 23:13 |
Director's Dealing
FORM 4
|
English | 7.7 KB | ||
| 2025-11-03 12:09 |
Regulatory News Service
CURRENT REPORT
|
English | 738.5 KB | ||
| 2025-11-03 12:02 |
Prospectus
424B2
|
English | 609.2 KB | ||
| 2025-10-31 14:48 |
Major Shareholding Notification
|
English | 8.6 KB | ||
| 2025-10-30 17:04 |
Quarterly Report
10-Q
|
English | 2.3 MB | ||
| 2025-10-30 12:09 |
Regulatory News Service
8-K
|
English | 2.9 MB | ||
| 2025-10-06 23:22 |
Director's Dealing
FORM 4
|
English | 7.4 KB | ||
| 2025-10-03 00:20 |
Director's Dealing
FORM 4
|
English | 7.4 KB | ||
| 2025-10-03 00:18 |
Director's Dealing
FORM 4
|
English | 7.3 KB |
Automate Your Workflow. Get a real-time feed of all BRISTOL MYERS SQUIBB CO filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRISTOL MYERS SQUIBB CO
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRISTOL MYERS SQUIBB CO via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
